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Abstract
Adult  CNS  neurons  exhibit  a  reduced  capacity  for  growth  compared  to  developing  neurons,  due  in  part  to
downregulation of growth-associated genes as development is completed. We tested the hypothesis that SnoN, an
embryonically regulated transcription factor that specifies growth of the axonal compartment, can enhance growth in
injured  adult  neurons.  In  vitro,  SnoN  overexpression  in  dissociated  adult  DRG  neuronal  cultures  significantly
enhanced neurite outgrowth. Moreover, TGF-β1, a negative regulator of SnoN, inhibited neurite outgrowth, and SnoN
over-expression overcame this inhibition. We then examined whether SnoN influenced axonal regeneration in vivo:
indeed, expression of a mutant form of SnoN resistant to degradation significantly enhanced axonal regeneration
following cervical spinal cord injury, despite peri-lesional upregulation of TGF-β1. Thus, a developmental mechanism
that specifies extension of the axonal compartment also promotes axonal regeneration after adult CNS injury.
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Introduction
Several  mechanisms  contribute  to  the  failure  of  axonal
regeneration  in  the  adult  central  nervous  system,  including
factors  both  intrinsic  and  extrinsic  to  the  neuron.  The
importance  of  neuron-intrinsic  mechanisms  in  regeneration
failure are illustrated by the effects of a “conditioning” lesion,
wherein  injury  to  the  peripheral  process  of  a  dorsal  root
ganglion (DRG) neuron substantially enhances regeneration of
the central process of the same neuron after spinal cord injury
[1,2],  mediated  in  part  by  upregulation  of  neuronal
regeneration-associated genes [3–5]. However, the full set of
intrinsic  neuronal  mechanisms  that  underlie  central  axonal
regeneration failure remain poorly understood.
Studies  of  neural  development  may  provide  insight  into
neuron-intrinsic mechanisms influencing axonal growth, since
developing  axons  generally  exhibit  greater  growth  capacity
than mature neurons [6,7]. SnoN is of particular interest in this
respect:  SnoN  is  a  developmentally  regulated  gene  that
specifies  growth  of  the  developing  axonal  compartment  [8].
Overexpression  of  SnoN  itself,  or  a  mutant  form  of  SnoN
resistant  to  ubiquitination  and  degradation,  leads  to
enhancement  of  growth  in  developing  neurons  specifically  in
the  axonal  compartment  [8].  Moreover,  SnoN-mediated
enhancement of axonal growth during development appears to
be  terminated  by  transforming  growth  factor-beta  (TGF-β),
which facilitates SnoN ubiquitination and degradation through
induction of SMAD2 phosphorylation [9].
Accordingly,  we  examined  alterations  in  these  signaling
systems in adult neurons in vitro and after spinal cord injury in
vivo.  We  now  find  that  enhancement  of  SnoN  signaling
significantly enhances growth from adult dorsal root ganglion
neurons in vitro, and significantly enhances axon regeneration
after spinal cord injury.
Materials and Methods
The  VA  Institutional  Animal  Care  and  Use  Committee
approved  this  research.  National  Institutes  of  Health  and
Institutional Animal Use and Safety Committee guidelines for
laboratory animal care and safety were strictly followed for all
animal use and post-operative care.
Experimental Design
We  first  examined  effects  of  SnoN  and  its  negative
modulator, TGFβ1, on neurite outgrowth in cultured adult DRG
neurons. Next, we examined whether expression of a mutated
form of SnoN that is resistant to degradation enhanced axonal
regeneration after C3 spinal cord injury.
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We  generated  dual  promoter  expression  vectors  that
expressed copepod green fluorescent protein (copGFP) as a
reporter,  and  either:  1)  the  2055  bp  cDNA  for  SnoN;  2)  a
mutant,  ubiquitination/degradation-resistant  form  of  SnoN
containing  a  D-Box  mutation  (SnoN-DBM)  in  its  base  pair
coding region of 490-501 [10]; or 3) a control vector expressing
the reporter gene GFP (i.e., a GFP – copGFP vector). GFP,
GFP-SnoN,  or  GFP-SnoN-D-box  mutation  plasmids  were
expressed by a hybrid chick beta actin – minimal CMV (CAG)
promoter,  and  the  reporter  gene  copGFP  was  driven  by  an
EF1-α  promoter,  as  previously  described  [11].  To  facilitate
histological detection of SnoN, we fused the GFP reporter to
the amino terminal of SnoN; the resulting fusion protein was
functional, as shown in Results. Vectors were cloned into an
adeno-associated  virus  serotype  6  backbone  (AAV6),  as
previously described [11].
For  in  vivo  studies,  we  generated  single-stranded
recombinant  AAV-serotype  6  viral  vectors  containing  the
human cytomegalovirus promoter, SV40 intron, enhanced GFP
or SnoN-DBM transgene, and a SV40 poly adenylation signal.
Vector  production  was  performed  by  the  Vector  Core  at  the
University  of  North  Carolina  using  methods  previously
described [12]. Briefly, HEK293 cells were transfected with the
appropriate plasmids by CaCl2 transfection and resultant viral
particles  were  purified  over  CsCl  density  gradients.  Dot-blot
DNA hybridization was used to determine viral titers. Prior to
surgery, viral stocks were diluted to 1.0x1012 infectious units/ml
in Hanks’ balanced salt solution.
Figure 1.  SnoN Promotes Neurite Outgrowth From Adult DRG Cultures.  (A) Western blot from HEK293 cells electroporated to
express GFP, wild-type SnoN, SnoN-DBM, GFP fused SnoN, and GFP fused SnoN-DBM. Cells transfected with wild-type SnoN
and SnoN-DBM demonstrate SnoN immunoreactive bands at ~75 kD (lane 3 and 4). Cells transfected with GFP-SnoN and GFP-
SnoN-DBM demonstrate SnoN immunoreactive bands and corresponding GFP immunoreactive bands at ~110 kD, a molecular
weight consistent with expression a GFP fused variant. (B) Neurite outgrowth from control adult DRG neurons in vitro. NF200 label.
(C)  Overexpression  of  SnoN  increases  neurite  length,  quantified  in  E.  Infected  cells  express  GFP  and  are  labeled  for  NF200
(shown).  (D)  Overexpression  of  SnoN-D-box  mutation  further  amplifies  neurite  growth.  (E)  Quantification  confirms  that  SnoN
expression in adult DRG neurons significantly enhances neurite growth (ANOVA p<0.001; post hoc Fisher’s ***p<0.001 comparing
treated groups to GFP, and **p<0.01 comparing SnoN to SnoN-DBM group).
doi: 10.1371/journal.pone.0071906.g001
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DRGs  were  dissected  from  adult  female  Fisher  344  rats
weighing  150-165  g,  digested  in  0.25%  collagenase  type  XI
and 5µg/ml dispase, and triturated. For transfections, 1 million
cells and 10 µg of DNA were used according to Nucleofactor
(Lonza)  protocols.  Briefly,  cells  were  centrifuged  and
resuspended  in  Rat  Neuron  Nucleofector  solution.  Cell
suspensions  were  mixed  with  DNA  and  transferred  to  a
cuvette. Suspensions were electroporated using Nucleofector
Program  G-013  and  seeded  at  low  density  on  cell  culture
plates  (Corning  #3516)  coated  with  poly-L-lysine  (20µg/mL)
and  laminin  (0.5µg/mL;  this  is  a  low  dose  of  laminin  that
facilitates detection of enhanced outgrowth after administration
of test substances). Cells were cultured in media (DMEM: F12
supplemented with B27, 100U/mL penicillin-streptomycin, and
2mM  glutamine,  Invitrogen)  supplemented  with  TGF-β1  (100
ng/ml). Cells were fixed with 4% PFA after two days in vitro and
labeled  for  βIII-tubulin  (@1:1000  concentration;  Promega
G712A),  NF200  (@1:6000  concentration;  Chemicon
MAB5262),  and  copGFP  (@1:5000  concentration;  Evrogen
AB502).  Images  were  acquired  using  an  ImageXpress  Micro
system  (Molecular  Devices)  and  analyzed  using  the  neurite
outgrowth  module  of  the  MetaXpress  software  package.  For
quantification of transfected neurons, only neurons expressing
the  copGFP  reporter  were  analyzed.  The  program  software
traces the processes of all objects with neuronal morphology,
and in an automated fashion provides mean neurite length and
longest neurite from each cell. Optimization of the software was
performed prior to use in this experiment to ensure that object
identification  by  the  automated  system,  and  neurite
quantification, were consistent with manual methods performed
on  sample  photographed  images  by  human  observers.  Cells
were plated at sufficiently low densities to permit identification
of individual neurons and their processes in more than 95% of
sampled neurons. All experiments were repeated in triplicate
and a minimum of 150 neurons per condition were quantified.
Protein Isolation and Western Blot Analysis
Protein was extracted from DRG cultures or from adult L4
and  L5  DRGs  using  RIPA  buffer.  Protein  concentration  was
determined  using  Bio-Rad  Protein  Assay  and  20  µg  was
resolved on a 4-12% SDS-PAGE gel (Invitrogen). The gel was
transferred to 0.45 µm PVDF membranes (Millipore), blocked
with 5% nonfat milk, washed with 0.05% Tween-20 in PBS, and
incubated  with  anti-pSMAD2  (@1:1000  concentration;  Cell
Signaling  #3101),  anti-SMAD2  (@1:1000  concentration;  Cell
Signaling #3103), or anti-SnoN (@1:1000 concentration; Cell
Signaling  #4973).  Blots  were  washed  and  incubated  with
horseradish peroxidase conjugated secondary antibodies and
visualized  and  analyzed  using  chemiluminescence  on  a  Bio-
Rad GelDoc. Blots were then stripped and reblotted with anti-β-
actin (@1:1000; Cell Signaling #3700) for loading controls.
Figure 2.  SnoN Overexpression Overcomes TGF-β1 Inhibition.  (A) Neurite outgrowth in primary adult DRG neurons in the
presence of TGF-β1. Cells expressing GFP and NF200 (shown) are quantified. (B) Overexpression of SnoN in neurons appears to
increase neurite length even in presence of TGF-β1, quantified in D. (C) Overexpression of SnoN-D-box mutation also appears to
increase neurite growth. (D) Quantification reveals that overexpression of TGF-β1 overcomes TGFß-1-mediated inhibition (ANOVA
p<0.001; post hoc Fisher’s *p<0.05, **p<0.01).
doi: 10.1371/journal.pone.0071906.g002
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Adult  female  Fisher  344  rats  weighing  150-165  g  were
anesthetized with a mixture (2 ml/kg) of ketamine (25 mg/ml),
rompun (1.8 mg/ml) and acepromazine (0.25 mg/ml). National
Institutes  of  Health  and  Institutional  Animal  Use  and  Safety
Committee  guidelines  for  laboratory  animal  care  and  safety
were  strictly  followed  for  all  animal  use  and  post-operative
care.  For  intraganglionic  injections,  the  vertebrate  overlaying
the L4 and L5 DRGs were removed and 1 µl per DRG of AAV6
(1.0x1012 infectious units/ml) was injected into the L4 and L5
DRGs  bilaterally  using  a  pulled  glass  micropipette  and
picospritzer.  Great  care  was  taken  to  avoid  damage  to  the
injected DRG as this might “condition” the neurons. One week
later,  C3  dorsal  column  lesions  were  performed  using  a
tungsten wire knife in 27 animals. The lesion site was filled with
syngeneic bone marrow stromal cells to provide a matrix in the
lesion site to which injured axons could attach and grow [1,13];
without such a matrix, axons are unable to regenerate into the
lesion.  Rat  marrow  stromal  cells  were  accordingly  prepared
[1,14] and transplanted into the lesion site using glass pipettes
and  a  picospritzer;  2  µl  were  injected  at  a  concentration  of
50,000 cells/µl over one minute. 12 animals received lesions
and  injections  of  SnoN-DBM  into  the  L4/5  DRGs,  and  11
control-lesioned animals received injections of AAV6-GFP into
the L4/5 DRGS. Four additional controls received lesions and
cells  only  without  vector  injections.  Four  weeks  after  lesions
and three days prior to perfusion, dorsal column sensory axons
were  labeled  transganglionically  by  cholera  toxin  B  subunit
(CTB) injection into the sciatic nerve (2 µl of 1% solution per
sciatic nerve) as described previously [1,15–17]. Animals were
then transcardially perfused with 4% paraformaldehyde, post-
fixed overnight, and cryoprotected in 30% sucrose at 4° C.
For  immunolabeling  of  DRGs,  L4  and  L5  DRGs  were
sectioned  on  a  cryostat  set  at  10µm  thickness,  directly
mounted on microscope slides, and thoroughly dried. Sections
were  washed  with  tris-buffered  saline  and  blocked  with  5%
goat  serum  for  1  hr  at  room  temperature.  Sections  were
incubated overnight at 4° C with anti-GFP (@1:1000; Invitrogen
A6455),  anti-SnoN  (@1:1000  concentration;  Santa  Cruz
SC-9141),  or  βIII-tubulin  (@1:1000  concentration;  Cell
Signaling #2128). After washing, sections were incubated with
Alexa 488 and/or Alexa 594 secondary antibodies for 2.5 hr at
room temperature.
Spinal cords were sectioned sagittally on a cryostat set to 30
µm  intervals.  All  sections  were  processed  free-floating.  For
visualization  of  CTB-labeled  sensory  axons,  endogenous
peroxidase activity was blocked with 0.6% hydrogen peroxide
and  non-specific  antibody  reactions  were  blocked  with  5%
horse  serum  for  1  hr  at  room  temperature.  Sections  were
Figure 3.  Effects of SnoN Expression on Axonal Regeneration After Spinal Cord Injury.  Sensory axonal regeneration was
assessed in rats that underwent C3 spinal cord dorsal column lesions. Overview of lesion/graft site in sagittal sections; caudal is to
the right and rostral is to the left. CTB-labeled dorsal column sensory axons approach the lesion site from the caudal aspect of the
section in panels A and B. Dashed lines indicate the lesion margins; arrowhead indicates the interface between dorsal white matter
and central gray; thin arrow indicates the interface between central gray and ventral white matter (VWM). Inset shows GFP labeling
in L4 DRG neurons, indicating persistent gene expression through the experimental period. (A) In a lesioned animal that received
SnoN-DBM, the dorsal column sensory projection is seen in the upper right hand corner of the section with CTB labeling, as it
approaches the lesion site which has been filled with bone marrow stromal cells to provide a permissive matrix for axonal growth.
Axons enter the lesion site, visible even at this low magnification. Higher magnification in Figure 5. Dashed lines indicate margins of
lesion. (B) In a control animal, few axons penetrate the lesion site, more clearly evident in Figure 5. Scale bar A, B: 400 µm.
doi: 10.1371/journal.pone.0071906.g003
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followed by incubation with a biotinylated horse anti-goat IgG
secondary antibody for 1 hr at room temperature. After 1 hr
incubation  in  avidin-biotin  peroxidase  complex  at  room
temperature,  diaminobenzidine  (0.05%)  with  nickel  chloride
(0.04%) were used as chromogens. Glial fibrillary acidic protein
(GFAP)  was  detected  subsequently  in  the  same  sections  by
fluorescence  labeling  using  anti-GFAP  (Chemicon  MAB360)
incubated  overnight  at  4°  C.  After  washes,  sections  were
incubated  with  Alexa  594  fluorophore-conjugated  secondary
antibody for 2.5 hr at room temperature. To quantify the mean
number of dorsal column sensory axons penetrating the lesion
site, a series of 1-in-6 sections was labeled for CTB and GFAP,
and the number of CTB-labeled axons present within the lesion
site was counted using a 10x ocular with a calibrated grid and a
40x  objective.  Multiple  axons  that  could  not  be  resolved  as
separate axons were quantified as a single axon. The observer
was  blinded  to  group  identity.  To  compensate  for  individual
differences in efficiency of axon tracing between subjects, the
total number of dorsal column sensory axons intersecting a line
Figure 4.  SnoN Promotes Axonal Regeneration After Spinal Cord Injury.  Sensory axonal regeneration into site of C3 dorsal
column lesion. (A, C) Animal treated with SnoN-DBM exhibits regeneration into lesion site. Boxed region is magnified in C, a region
entirely  with  the  lesion  site.  Axons  exhibit  circuitous  trajectories  and  make  abrupt  turns,  consistent  with  regenerating  axons
(Tuszynski, 2012). Dashed lines indicate the caudal lesion/host interface. (B, D) Control subjects exhibit few axons within lesion
site. Boxed region is entirely within the lesion site and is shown in D. (E) Another animal that received SnoN-DBM. Several axons
are present in the central-distal aspect of lesion site, shown at higher magnification in F (arrow). Lesion margins are indicated by
dashed lines. Significantly greater numbers of axons penetrate SnoN-DBM treated animals (P < 0.005; see text). Scale bar A, B:
250 µm; C, D: 100 µm; E, 175 µm; F, 50 µm.
doi: 10.1371/journal.pone.0071906.g004
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The  mean  number  of  axons  penetrating  the  lesion  site  was
expressed as a proportion of total axons labeled per subject.
Results were expressed as mean ± SEM.
Statistical Analysis
Differences among multiple treatment groups were assessed
using  one-way  ANOVA  with  a  significance  level  of  p<0.05;
individual  group  differences  were  assessed  using  post-hoc
Fischer’s.  Comparison  of  two  groups  was  made  using  two-
tailed  Student’s  t-test  with  a  significance  criterion  of  p<0.05.
Data are presented as mean ± standard error of the mean. All
analyses were performed in a blinded manner.
Results
SnoN Promotes Neurite Outgrowth from Adult DRG
Neurons In Vitro and Overcomes TGF-β1-Related
Inhibition
During neural development, SnoN specifies elongation of the
developing axon [8–10]. Accordingly, we determined whether
overexpression  of  SnoN,  or  expression  of  a  mutant  form  of
SnoN resistant to ubiquitination and degradation (SnoN with a
D-Box-Mutation, or SnoN-DBM), enhanced neurite growth from
adult  DRGs.  The  SnoN  and  SnoN-DBM  plasmids  expressed
both SnoN and the reporter gene GFP of the predicted size
(Figure 1A). Notably, overexpression of both SnoN and SnoN-
DBM  resulted  in  significant  increases  in  neurite  outgrowth
compared  to  control  neurons  after  48  hr  in  vitro  (ANOVA
p<0.001;  post-hoc  Fischer’s  p<0.001  comparing  both
conditions to control cells; Figure 1B–E).
Figure  5.    Quantification  of  SnoN-Induced  Axonal
Regeneration.  Quantification reveals a 3-fold increase in the
number  of  axons  regenerating  into  the  lesion  site  among
animals treated with SnoN-DBM. * p<0.001.
doi: 10.1371/journal.pone.0071906.g005
TGF-β1  acts  as  a  negative  regulator  of  SnoN  and  is
associated with a reduction in axonal growth capacity during
neural  development  [8–10].  We  examined  whether  TGF-β1
also inhibits neurite outgrowth from adult DRG neurons, and
whether  overexpression  of  SnoN  or  SnoN-DMB  could
overcome inhibition. TGF-β1 (100 ng/ml) significantly reduced
neurite  outgrowth  compared  to  GFP-expressing  control  cells
(ANOVA p<0.001; post-hoc Fischer’s p<0.05 comparing GFP
alone  to  GFP  +  TGF-ß1;  Figure  2A,  D).  Overexpression  of
SnoN  or  SnoN-DBM  in  the  presence  of  TGF-β1  significantly
increased  neurite  outgrowth  compared  to  cultures  in  the
presence  of  TGF-β1  (ANOVA  p<0.05,  post-hoc  Fischer’s
p<0.01; Figure 2B–D). Moreover, maximum neurite length also
exceeded  findings  compared  to  control  DRG  neurons  that
lacked  TGF-β1  exposure  (p<0.05,  post-hoc  Fischer’s;  Figure
2D).  Given  these  collective  findings  that  SnoN  can  promote
neurite  outgrowth  and  overcome  TGF-β1-related  neurite
inhibition, we proceeded to in vivo studies in models of spinal
cord injury.
SnoN Promotes Axonal Regeneration After Spinal Cord
Injury
For  in  vivo  studies  of  spinal  cord  injury,  we  used  the
degradation-resistant D-box mutant form of SnoN because of
its  greater  effect  in  the  adult  DRG  neurite  outgrowth  assay
(Figure 1). AAV6 vectors expressing either GFP or SnoN-DBM
were  injected  into  the  L4  and  L5  dorsal  root  ganglia  using
cautious  surgical  technique  and  minimal  tissue  disruption  to
avoid a traumatic injection-related “conditioning” effect. Gene
expression  persisted  throughout  the  experimental  period,
reflected by GFP labeling (Figure 3B, inset). C3 dorsal column
lesions were placed, and the lesion site in both GFP and SnoN-
DBM groups was filled with marrow stromal cells to provide a
permissive  matrix  for  axon  growth;  without  a  matrix,  axons
cannot  penetrate  the  cystic  lesion  site  [1,13].  Notably,  four
weeks after lesions, a significant, 3-fold increase in the total
number  of  CTB-labeled  dorsal  column  sensory  axons
regenerating into the lesion site was observed in animals that
received  infusions  of  SnoN-DBM  compared  to  controls
(p<0.001; Figures 3-5). Moreover, when compared to the total
number  of  CTB-labeled  axons  in  the  dorsal  column  tract
approaching  the  lesion,  31%  of  all  sensory  axons  in  SnoN-
DBM-treated  animals  regenerated  into  the  lesion  site,
compared  to  only  7.7%  in  controls,  a  4-fold  increase.  There
was no significant difference in the efficiency of axonal labeling
in the control and SnoN-DBM groups in the main dorsal column
sensory  tract  approaching  the  lesion  site  (p  =  0.8).  Thus,
targeting  of  SnoN,  a  developmentally-regulated  axonal
transcription factor, significantly enhances axonal regeneration
after adult spinal cord injury.
Assessment of in vivo axonal regeneration must ensure that
regenerating  axons  are  not  mistaken  for  spared  axons:
examination of the spinal cord and medulla rostral to the lesion
site  showed  an  absence  of  CTB-labeled  axons,  indicating
lesion  completeness  in  all  subjects  (not  shown).  Taken
together,  these  results  indicate  that  SnoN  overexpression
significantly  enhances  axonal  regeneration  after  spinal  cord
injury.
SnoN and Spinal Cord Injury
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Findings  of  this  study  reveal  for  the  first  time  that  a
developmentally-regulated  transcription  factor  specifically
related to extension of the developing axon, SnoN, enhances
growth of adult axons both in vitro and in vivo after spinal cord
injury. While the function of SnoN in neural development has
been the subject of previous studies [8,9,18–21], a role for this
molecule  in  adult  nervous  system  injury  has  not  previously
been described.
SnoN was first identified in a screen for genes modulating
the oncogene c-ski [22]. It has subsequently been shown to act
as a regulator of the cellular growth state both in the context of
cancer biology and neurobiology, exerting effects on a number
of  different  cell  types  [23].  Many  of  its  actions  are  mediated
through  regulation  of  TGF-β  signaling,  often  interacting  with
Smads and components of the histone deacetylase complex to
influence  the  cell  cycle  [24–26].  SnoN  appears  to  act  as  an
oncogene and a tumor suppressor gene [23], a role it shares
with  other  recently  identified  molecules  that  have  also  been
shown to modulate adult CNS axonal regeneration, including
PTEN  [27].  More  specifically  in  the  context  of  neural
development, SnoN exerts effects on post-mitotic neurons by
critically  regulating  axonal  morphogenesis  [8].  Knockdown  of
SnoN  in  post-natal  primary  granule  neurons  profoundly  and
specifically  retards  axon  growth  [8].  Levels  of  SnoN  are
dynamically  regulated  during  development  by  the  ubiquitin
ligase Cdh1-APC, and developmental regulation of Cdh1-APC,
TGFβ and SnoN levels correlates strongly with distinct periods
of  axonal  growth  and  termination  of  axon  growth  [9].  More
recently,  roles  for  SnoN  in  neuron  branching,  migration  and
positioning have also been described [23]. With a specific role
in  promoting  elongation  of  the  axon,  SnoN  represented  a
compelling target for examination in a model of adult central
axonal regeneration. As we now demonstrate, overexpression
of SnoN indeed enhances neurite outgrowth from adult DRG
neurons  and  enhances  the  regeneration  of  these  same
neurons after in vivo spinal cord injury, recapitulating its role in
axonal outgrowth during development.
In  general,  molecular  mechanisms  that  influence  axon
outgrowth during development have in many cases also been
shown to influence growth of the axon after injury in adulthood,
including  neurotrophic  factors,  diffusible  guidance  molecules
(e.g., netrins, semaphorins, ephrins), transcriptional regulators
(e.g., Id2, which like SNoN is modulated by Cdh1-APC [28])
and now, SnoN. Yet the regulation of many of these molecular
mechanisms during development is complex, illustrated clearly
by  the  role  of  netrins  and  semaphorins  in  development  [29].
Simple  overexpression  or  knockdown  approaches  may  not
always  yield  clear  effects.  But  in  the  case  of  SnoN
overexpression,  significantly  enhanced  axonal  growth  after
spinal cord injury is observed, supporting a potentially useful
translational role for this molecule in enhancing plasticity and
regeneration.
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